乳腺癌患者内分泌治疗依从性常见问题及改善策略的研究进展

doi:10.3761/j.issn.1672-9234.2023.03.023

摘要/Abstract

摘要：

该文阐述了乳腺癌患者内分泌治疗依从性常见问题及改善依从性行为的干预措施，以期为医护人员制订乳腺癌患者内分泌治疗依从性管理方案提供参考依据。

关键词: 乳腺肿瘤, 肿瘤护理, 服药依从性, 健康教育, 综述, 内分泌治疗

Abstract:

This article describes the common problems of endocrine therapy compliance in breast cancer patients and the intervention measures to improve the compliance behavior. This review aims to provide a reference for the development of endocrine therapy compliance management plan for breast cancer patients.

Key words: Breast Neoplasms, Oncologic Nursing, Medication Adherence, Health Education, Review, Endocrine therapy

王琦, 赵培, 张红梅, 郭员志. 乳腺癌患者内分泌治疗依从性常见问题及改善策略的研究进展[J]. 中华护理教育, 2023, 20(3): 372-376.

WANG Qi, ZHAO Pei, ZHANG Hongmei, GUO Yuanzhi. Research progress on common problems and improvement strategies of endocrine therapy compliance in breast cancer patients[J]. Chinese Journal of Nursing Education, 2023, 20(3): 372-376.

参考文献 38

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.v71.3
[2]	Burstein HJ, Lacchetti C, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer:ASCO clinical practice guideline focused update[J]. J Clin Oncol, 2019, 37(5):423-438. doi: 10.1200/JCO.18.01160 pmid: 30452337
[3]	Yao LT, Wang MZ, Wang MS, et al. Neoadjuvant endocrine therapy:a potential strategy for ER-positive breast cancer[J]. World J Clin Cases, 2019, 7(15):1937-1953. doi: 10.12998/wjcc.v7.i15.1937
[4]	Yanez B, Gray RJ, Sparano JA, et al. Association of modifiable risk factors with early discontinuation of adjuvant endocrine therapy:a post hoc analysis of a randomized clinical trial[J]. JAMA Oncol, 2021, 7(8):1-7.
[5]	Jiang HR, Dong Y, Zong W, et al. The relationship among psychosocial adaptation,medication adherence and quality of life in breast cancer women with adjuvant endocrine therapy[J]. BMC Womens Health, 2022, 22(1):135. doi: 10.1186/s12905-022-01722-0
[6]	许辉, 王爱平. 乳腺癌内分泌治疗患者疾病健康知识掌握现状及影响因素分析[J]. 中国医科大学学报, 2022, 51(10):896-901.
	Xu H, Wang AP. Analysis of disease knowledge status and influencing factors in patients with breast cancer undergoing endocrine therapy[J]. J China Med Univ, 2022, 51(10):896-901.
[7]	侯艳玲, 颜琬华, 万绪明. 乳腺癌患者对辅助内分泌治疗认知程度与相关知识需求的质性研究[J]. 中国实用护理杂志, 2018, 34(3):212-216.
	Hou YL, Yan WH, Wan XM. Qualitative research on cognitive level of patients with breast cancer adjuvant endocrine therapy and needs of related knowledge[J]. Chin J Pract Nurs, 2018, 34(3):212-216.
[8]	荆凤, 邢唯杰. 乳腺癌患者内分泌治疗相关症状及非药物干预的研究进展[J]. 中华护理杂志, 2021, 56(4):635-640. doi: 10.3761/j.issn.0254-1769.2021.04.027
	Jing F, Xing WJ. Review of symptoms and non-pharmacological interventions among breast cancer survivors undergoing adjuvant endocrine therapy[J]. Chin J Nurs, 2021, 56(4):635-640. doi: 10.3761/j.issn.0254-1769.2021.04.027
[9]	陈霞, 罗凤. 乳腺癌患者辅助内分泌治疗依从性现状及对策的研究进展[J]. 中华乳腺病杂志(电子版), 2020, 14(2):116-119.
[10]	Xu H, Jin F, Zhang XJ, et al. Adherence status to adjuvant endocrine therapy in Chinese women with early breast cancer and its influencing factors:a cross-sectional survey[J]. Cancer Med, 2020, 9(11):3703-3713. doi: 10.1002/cam4.v9.11
[11]	闫静, 葛晓丽. 激素受体阳性乳腺癌患者术后内分泌治疗依存性影响因素分析及护理对策[J]. 中国药物与临床, 2020, 20(9):1574-1576.
[12]	Borreani C, Alfieri S, Infante G, et al. Aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer:profiles of psychological symptoms and quality of life in different patient clusters[J]. Oncology, 2021, 99(2):84-95. doi: 10.1159/000509651
[13]	Kroenke CH, Hershman DL, Gomez SL, et al. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system[J]. Breast Cancer Res Treat, 2018, 170(3):623-631. doi: 10.1007/s10549-018-4774-2
[14]	Abraham J, Caldera H, Coleman R, et al. Endocrine therapy and related issues in hormone receptor-positive early breast cancer:a roundtable discussion by the breast cancer therapy expert group(BCTEG)[J]. Breast Cancer Res Treat, 2018, 169(1):1-7. doi: 10.1007/s10549-018-4662-9
[15]	Bourmaud A, Rousset V, Regnier-Denois V, et al. Improving adherence to adjuvant endocrine therapy in breast cancer through a therapeutic educational approach:a feasibility study[J]. Oncol Nurs Forum, 2016, 43(3):E94-E103. doi: 10.1188/16.ONF.E94-E103
[16]	Shelby RA, Dorfman CS, Bosworth HB, et al. Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy(AET)[J]. Contemp Clin Trials, 2019, 76:120-131. doi: 10.1016/j.cct.2018.11.010
[17]	陈晓燕, 许容芳, 王艳, 等. 口服内分泌药物治疗乳腺癌患者实施行为改变模式健康教育的效果观察[J]. 护理学报, 2019, 26(10):68-72.
	Chen XY, Xu RF, Wang Y, et al. Effect of health education based on behavior change mode on breast cancer patients with endorine therapy[J]. J Nurs(China), 2019, 26(10):68-72.
[18]	Markopoulos C, Neven P, Tanner M, et al. Does patient education work in breast cancer? Final results from the global CARIATIDE study[J]. Future Oncol, 2015, 11(2):205-217. doi: 10.2217/fon.14.179 pmid: 25591836
[19]	Çınar D, Karadakovan A, Erdoğan AP. Effect of mobile phone app-based training on the quality of life for women with breast cancer[J]. Eur J Oncol Nurs, 2021, 52:101960. doi: 10.1016/j.ejon.2021.101960
[20]	刘叶, 刘诗盈, 冯冬东, 等. 内分泌治疗期间创新途径随访对提高乳腺癌患者自我效能和韧性水平的影响[J]. 中国医科大学学报, 2019, 48(1):85-86.
[21]	雷雨蒙, 叶华容, 殷苗. 乳腺癌患者健康教育策略[J]. 中国妇幼保健, 2020, 35(9):1756-1758.
[22]	Çömez S, Karayurt Ö. The effect of web-based training on life quality and spousal adjustment for women with breast cancer and their spouses[J]. Eur J Oncol Nurs, 2020, 47:101758. doi: 10.1016/j.ejon.2020.101758
[23]	肖涵, 刘维, 荆海红. 配偶参与的健康教育在乳腺癌内分泌治疗患者中的应用[J]. 中华现代护理杂志, 2020, 26(22):3068-3071.
[24]	国家肿瘤质控中心乳腺癌专家委员会, 北京乳腺病防治学会健康管理专业委员会. 中国乳腺癌随诊随访与健康管理指南(2022版)[J]. 中华肿瘤杂志, 2022, 44(1):1-28.
	Breast Cancer Expert Committee of National Cancer Quality Control Center,Health Management Professional Committee of Beijing Breast Cancer Prevention and Control Society. Comprehensive management guideline for breast cancer follow-up and healthcare(2022 edition)[J]. Chin J Oncol, 2022, 44(1):1-28.
[25]	Castaldi M, Safadjou S, Elrafei T, et al. A multidisciplinary patient navigation program improves compliance with adjuvant breast cancer therapy in a public hospital[J]. Am J Med Qual, 2017, 32(4):406-413. doi: 10.1177/1062860616656250 pmid: 27357461
[26]	倪卫燕, 沈薇, 沈定玉, 等. 多学科团队协作对乳腺癌内分泌治疗依从性的效果[J]. 实用临床医药杂志, 2018, 22(22):139-141,153.
[27]	聂丽静, 奚凯雯, 韦嘉玲, 等. 个案管理模式下乳腺癌病人辅助内分泌治疗依从性分析[J]. 临床外科杂志, 2021, 29(3):235-238.
	Nie LJ, Xi KW, Wei JL, et al. Compliance analysis of adjuvant endocrine therapy for breast cancer patients under case management mode[J]. J Clin Surg, 2021, 29(3):235-238.
[28]	Ellsworth GB, Burke LA, Wells MT, et al. Randomized pilot study of an advanced smart-pill bottle as an adherence intervention in patients with HIV on antiretroviral treatment[J]. J Acquir Immune Defic Syndr, 2021, 86(1):73-80. doi: 10.1097/QAI.0000000000002519 pmid: 33306564
[29]	Park HR, Kang HS, Kim SH, et al. Effect of a smart pill bottle reminder intervention on medication adherence,self-efficacy,and depression in breast cancer survivors[J]. Cancer Nurs, 2022, 45(6):E874-E882. doi: 10.1097/NCC.0000000000001030
[30]	朱叶卉. 乳腺癌患者内分泌治疗服药依从性现况及护士主导的个体化随访干预方案构建研究[D]. 上海: 复旦大学, 2013.
	Zhu YH. Adherence to hormonal therapy and the formation of nurse-led individualized follow-up for breast cancer patients[D]. Shanghai: Fudan University, 2013.
[31]	Graetz I, McKillop CN, Stepanski E, et al. Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors:a randomized controlled feasibility trial[J]. J Cancer Surviv, 2018, 12(4):431-440. doi: 10.1007/s11764-018-0682-z pmid: 29492753
[32]	Mougalian SS, Epstein LN, Jhaveri AP, et al. Bidirectional text messaging to monitor endocrine therapy adherence and patient-reported outcomes in breast cancer[J]. JCO Clin Cancer Inform, 2017, 1:1-10. doi: 10.1200/CCI.17.00015 pmid: 30657377
[33]	王春青, 胡雁, 吴密彬, 等. 乳腺癌患者内分泌治疗服药监控平台的设计及应用[J]. 中华护理杂志, 2017, 52(3):261-266.
	Wang CQ, Hu Y, Wu MB, et al. The effectiveness of computer-based monitoring system for patients with breast cancer receiving adjuvant hormonal therapy[J]. Chin J Nurs, 2017, 52(3):261-266.
[34]	文翠菊, 王玥妮, 孙红娟, 等. 乳腺癌患者芳香化酶抑制剂治疗期间症状群及影响因素分析[J]. 中国实用护理杂志, 2022, 38(2):132-139.
	Wen CJ, Wang YN, Sun HJ, et al. Analysis on the symptom clusters and influencing factors among breast cancer patients during aromatase inhibitors treatment[J]. Chin J Pract Nurs, 2022, 38(2):132-139.
[35]	蒋尊丽. 定期心理干预对乳腺癌患者内分泌治疗依从性的影响[J]. 中国医科大学学报, 2016, 45(12):1145-1147.
[36]	Hoffman CJ, Ersser SJ, Hopkinson JB, et al. Effectiveness of mindfulness-based stress reduction in mood,breast- and endocrine-related quality of life,and well-being in stage 0 to III breast cancer:a randomized,controlled trial[J]. J Clin Oncol, 2012, 30(12):1335-1342. doi: 10.1200/JCO.2010.34.0331
[37]	朱艳, 鲍咏咏, 李小泉. 行为改变模式联合门诊随访对乳腺癌患者的影响[J]. 齐鲁护理杂志, 2021, 27(3):137-139.
[38]	Bright EE, Stanton AL. Prospective investigation of social support,coping,and depressive symptoms:a model of adherence to endocrine therapy among women with breast cancer[J]. J Consult Clin Psychol, 2018, 86(3):242-253. doi: 10.1037/ccp0000272 pmid: 29265835